SAGE Interim recommendations for an extended primary series with an additional vaccine dose for COVID-19 vaccination in immunocompromised persons
|
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021. Interim guidance, 26 October 2021. |